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1.  Introduction 
Therapeutic ultrasound (US) is a common form of treatment the repair of damaged tissues.  
This non-invasive application of acoustic energy at low megahertz frequencies (up to 3000 mW / cm2) 
has been utilized to treat over one million patients each year in the UK, constituting 20% of all 
treatments within hospital physiotherapy departments [1]   
Beneficial responses to the application of US have been demonstrated in several soft tissue 
animal models, with improved healing rates [2] and tissue strength [3].  Moreover, clinical trials have 
also reported beneficial results at soft tissue wound sites such as venous ulcers [4] and the elbow joint 
[5].  In addition, US treatment of hard tissue injuries, such as bone fractures, have proved highly 
successful with markedly improved healing rates of human fractures (approximately 30-40%) [6,7].  
Animal studies have also provided evidence of enhanced fracture healing, particularly at the lower 
range of clinical intensity  values [8,9]. 
The potential for applying Therapeutic US to improve the clinical efficiency of implant 
materials has been demonstrated with improved rates of bone regeneration and bioabsorption of US-
treated DP-Bioglass implants [10] and also improved rates and extent of bone ingrowth using US-
treated porous-coated impants [11]. 
  The studies noted above and widespread clinical experience strongly suggest that there is a 
clear potential of the use of US as a non-invasive method to enhance tissue repair and regeneration 
processes.  However, the mechanisms involved in initiating favourable cellular responses from 
ultrasonic stimulation are poorly understood, and little is known about the optimum acoustical 
conditions which elicit such beneficial responses.  The aim of this study was therefore to determine the 
relationship between intensity levels of applied US and activity of two bone-associated genes, alkaline 
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phosphatase (ALP) and osteopontin (OP), which play fundamental roles in the growth and function of 
bone.  
 
2.  Materials and methods 
The osteoblast-like cell line MG63 was seeded onto 10 cm2 slide chamber flasks (Nunc; 
Naperville; IL; USA) and grown to confluence in medium consisting of Dulbecco’s Minimum 
Essential Medium (DMEM) (Gibco Life Technologies Ltd; Paisley, UK), 10% heat-inactivated fetal 
calf serum (FCS) (PAA Laboratories; Linz, Austria), 2 mM L-glutamine (Gibco), 100 U/ml of 
penicillin (Gibco) and 100 mg/ml of streptomycin (Gibco) at 37°C in a humidified atmosphere of 5% 
CO2 in air.   The flasks were filled with medium and then exposed 3.0 MHz ultrasound for 10 min, at 
intensity levels of 120, 390 and 1490 mW / cm2. Control cultures received no exposure to US.  
Exposure was performed in a water bath exposure assembly, as shown in Fig. 1.  Cells from within a 
16 mm central circular target region of the flask were then detached by treatmernt with 0.25% Trypsin / 
0.02% EDTA (Gibco) 6 h after exposure and used in the experiments.  A 1.0 mm diameter PVdF 
needle hydrophone , housed within a purpose built plotting assemby, was used to calibrate the 
ultrasonic field from a 25 mm diameter ultrasonic probe within this target area. 
In order to characterise the osteoblast gene expression, we used the reverse-transcription 
polymerase chain reaction (RT-PCR), a sensitive and versatile technique used to determine the 
presence or absence of a gene transcript and to estimate it’s expression levels. RT-PCR is a relatively 
simple technique by which a complimentary DNA (cDNA) template is amplified many times quickly 
and reliably. The PCR process generates sufficient material for subsequent experimental analyses. The 
entire amplification can be performed in vitro. While most biochemical analyses, including nucleic 
acid detection with radioisotopes, require the input of significant amounts of biological material, the 
RT-PCR process requires very little.  
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Cells were harvested by trypsinisation and subsequent centrifugation. RNA was isolated from 
cells within the slide chamber target region by the single step method of Chomcynski  and Sacchi [12]. 
Briefly, it was important to achieve this rapidly and efficiently to inhibit the endogenous ribonucleases, 
which are present in virtually all living cells. High-quality RNA greatly increases the efficiency of RT-
PCR.  The isolated RNA was then reverse transcribed into first strand complimentary DNA (cDNA), 
and then amplified using oligonucleotide primers specific for the bone-associated proteins ALP and 
OP, using a previously published protocol [13].  Glyceraldehyde-3-phosphate hydrogenase (GAPDH), 
a ‘housekeeping’ gene whose activity remains constant in all mammalian cells, was also amplified as 
an internal control.  The PCR process amplifies short (approximately 100-1000 base pairs) segments of 
the longer cDNA molecule. The components of the reaction are mixed and the reaction is placed in a 
programmable thermal cycler, which is an automated instrument that takes the reaction through a series 
of different temperatures for varying amounts of time. This series of temperature and time adjustments 
is referred to as one cycle of amplification. Each PCR cycle theoretically doubles the amount of 
targeted template sequence in the reaction. Ten cycles theoretically multiply by a factor of about one 
thousand; 20 cycles, by a factor of more than a million in a matter of hours.  Each cycle of PCR 
amplification consists of a number of steps. Each step denatures the template producing two 
oligonucleotide-primed single-stranded DNA templates, sets up the polymerisation reaction, and 
synthesises a copy of each strand of the template being targeted. These steps were optimised for each 
template and primer pair combination. Thus, for each primer 40, 36 and 28 cycles were used for ALP, 
OP and GAPDH primers respectively.  The amplified products are loaded on the gel along with a 
reference DNA ‘ladder’ containing known DNA fragments of particular sizes (in base pairs). The gel 
also contains ethidium bromide so that it can be viewed under UV illumination. Thus, if the sequences 
under investigation are present, the illuminated bands will be revealed and their sizes checked against 
the DNA ladder. 
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3. Results 
 
Fig. 2 shows representative agarose gels of the RT-PCR products of ALP and OP with their 
corresponding GAPDH gels obtained from the mRNA transcripts of cells incubated for 6 h after 
insonation with 0 (control), 120, 390 and 1490 mW / cm2 at 3.0 MHz.  The resultant gels were subject 
to image analysis using Scion Image software to record band intensities relative to background 
intensity levels, which are presented in Fig. 3. for ALP and Fig. 4. for OP, respectively.  From the area 
of the histogram, the ratio of ALP or OP gene expression to GAPDH gene expression at each dose of 
ultrasound was calculated, and presented as an Expression Index (E.I.).  From this E.I., expression at 
each US intensity, relative to non-exposed control, was calculated. 
Thus, although the GAPDH remained at the same band intensity for all doses of ultrasound (and 
the same as the control cultures which recorded no ultrasound exposure), the expression of the both the 
ALP and OP genes were found to vary at different US intensities.  As seen in Fig. 3., ALP expression 
relative to GAPDH expression was found to be 10% above control levels for 120 mW / cm2, in excess 
of double at 390 mW / cm2 and more than four times greater at 1490 mW / cm2.  However, OP 
expression (Fig. 4.) was down-regulated by 40% at the lowest dose of 120 mW / cm2, while up-
regulation by 30% and 60% was measured at 390 mW / cm2 and 1490 mW / cm2 respectively.   .   
 
4.  Discussion and conclusion 
Exposure to therapeutic doses of US was found to alter the expression of the bone-associated genes 
ALP and OP at 6 h post-insonation in osteoblast-like cells.  At the highest two doses, ALP and OP 
expression were both clearly up-regulated, particularly for ALP.  However at the lowest dose, a 
differential response was found with down-regulation of OP to little variation from control for ALP. 
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These results suggest that clinical therapy using ultrasound may be mediated, at least partly, by 
altered expression of these genes due to ultrasound stimulation, such as up-regulation of ALP and OP 
at higher doses.  However, the down-regulation of OP at the lowest intensity exposure may infer that 
the response of cells to ultrasound may be highly dose-specific.  Such an observation is consistent with 
findings of optimal fracture healing in vivo at the lower end of the therapeutic US intensity range. 
These results suggest the possibility that ultrasound exposure parameters could be modulated to 
optimise the clinical efficacy of ultrasound for engineering new bone and improving implant 
biocompatability. 
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Figure Legends 
 
 
Fig. 1.   A schematic diagram describing the US exposure apparatus. 
 
 
Fig. 2.  Representative electrophoretic agarose gels of the PCR products of ALP and OP genes in 
MG63 cells exposed to different intensities of US. For each bone marker, the results are expressed 
relative to the expression of the housekeeping gene, GAPDH, used as an internal standard, and 
amplified by PCR from the same cDNA samples.  The size, in base pairs (bp) of each product is 
indicated. 
 
 
Fig. 3. Relative expression of GADPH and ALP mRNA transcripts for different US intensity 
exposures. The band intensity histograms show the Expression Index (E.I.) of ALP relative to GAPDH 
for each US dose. 
 
 
Fig. 4. Relative expression of GADPH and OP mRNA transcripts for different US intensity 
exposures. The band intensity histograms show the Expression Index (E.I.) of OP relative to GAPDH 
for each US dose. 
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Fig. 1.   Harle et al. 
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Fig. 2.   Harle et al. 
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Fig. 4.  Harle et al. 
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